FDA plans major overhaul, looks to be more specialized

Posted on February 12, 2014

5 months ago the FDA announced that in response to “unparalleled challenges” posed by advances in science, globalization and product complexity, the agency would need to realign its programs. With very little detail it was revealed that it would be led by a Program Alignment Group (PAG) consisting of all executive-level members of each of the FDA’s regulatory centers, as well as the Office of Regulatory Affairs (ORA).

In a memorandum distributed to high...